Fluoroazomycin arabinoside
Showing 1 - 25 of 47
Lung Cancer Trial in Toronto (18-F-FAZA)
Recruiting
- Lung Cancer
- 18-F-FAZA
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Cancer Centre
Oct 6, 2022
Cervix Cancer Trial in Toronto (18F-Fluoroazomycin Arabinoside (18F-FAZA))
Active, not recruiting
- Cervix Cancer
- 18F-Fluoroazomycin Arabinoside (18F-FAZA)
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Oct 21, 2022
Kidney Graft Fibrosis Trial in Toronto (FAZA PET/MRI scan)
Recruiting
- Kidney Graft Fibrosis
- FAZA PET/MRI scan
-
Toronto, Ontario, CanadaUniversity Health Network
Nov 25, 2022
Prostate Cancer Trial in Toronto (18F-Fluoroazomycin Arabinoside (18F-FAZA))
Recruiting
- Prostate Cancer
- 18F-Fluoroazomycin Arabinoside (18F-FAZA)
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 4, 2021
Malignant Breast Tumor, Malignant Colorectal Tumor, Malignant Pancreatic Tumor Trial in Houston (Computed Tomography, Fluorine F
Recruiting
- Malignant Breast Neoplasm
- +3 more
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 4, 2021
Sarcoma Trial in Toronto (18F-FAZA, Pimonidazole)
Recruiting
- Sarcoma
-
Toronto, Ontario, CanadaUniversity Health Network
Apr 11, 2022
Rhabdomyosarcoma, Non-Rhabdo. Soft Tissue Sarcoma Trial in Toronto (18F-FAZA (F18-Fluoroazomycin Arabinoside), Blood Oxygen
Enrolling by invitation
- Rhabdomyosarcoma
- Non-Rhabdo. Soft Tissue Sarcoma
- 18F-FAZA (F18-Fluoroazomycin Arabinoside)
- +3 more
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Nov 24, 2021
Tongue Cancer Trial in Toronto ((18)F-Fluoroazomycin arabinoside, Pimonidazole)
Recruiting
- Tongue Cancer
- (18)F-Fluoroazomycin arabinoside
- Pimonidazole
-
Toronto, Ontario, CanadaOdette Cancer Centre, Sunnybrook Health Sciences Centre
Oct 20, 2021
Critical Limb Ischemia Trial in Toronto (FAZA PET/MRI scan)
Unknown status
- Critical Limb Ischemia
- FAZA PET/MRI scan
-
Toronto, Ontario, CanadaUniversity Health Network
Nov 9, 2020
Uterine Cervical Tumors, Squamous Cell Carcinoma, Adenocarcinoma Trial in Canada (Metformin, Cisplatin, FAZA)
Completed
- Uterine Cervical Neoplasms
- +3 more
- Metformin
- +2 more
-
Calgary, Alberta, Canada
- +4 more
Apr 19, 2021
Skull Base Chordoma, Vertebral Chordoma Trial in Saint-Cloud (procedure, radiation, drug)
Active, not recruiting
- Skull Base Chordoma
- Vertebral Chordoma
- Surgery
- +2 more
-
Saint-Cloud, Ile De France, FranceInstitut Curie - Hôpital René Huguenin
Mar 30, 2022
Soft Tissue Sarcoma Trial in Toronto (Radiotherapy, Surgery)
Not yet recruiting
- Soft Tissue Sarcoma
- Radiotherapy
- Surgery
-
Toronto, Ontario, CanadaUniversity Health Network
Jul 10, 2023
Colon Rectal Cancer Adenocarcinoma Trial in Toronto
Completed
- Colon Rectal Cancer Adenocarcinoma
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Aug 15, 2019
PET-imaging in Squamous Cell Carcinoma Located in Head and Neck
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Intensity Modulated Proton Therapy (IMPT) +/- Chemotherapy
-
Delft, Zuid-Holland, NetherlandsHolland Proton Therapy Centre (HollandPTC)
Apr 1, 2022
Metastasized Gastro-Oesophageal Cancer Trial in Toronto (FAZA PET/MRI scan)
Recruiting
- Metastasized Gastro-Oesophageal Cancer
- FAZA PET/MRI scan
-
Toronto, Ontario, CanadaUniveristy Health Network
May 20, 2022
Renal Cell Carcinoma (RCC) Trial in Milan (18F-FAZA PET IMAGING TECHNIQUE IN DETECTING LYMPH NODE METASTASES IN RENAL CELL
Completed
- Renal Cell Carcinoma (RCC)
- 18F-FAZA PET IMAGING TECHNIQUE IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS
-
Milan, ItalyIRCCS San Raffaele
Dec 18, 2020
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Bisantrene Dihydrochloride (high dose)
- +3 more
-
Newcastle, New South Wales, AustraliaCalvary Mater
Jul 14, 2022
AML Trial in Puerto Rico, United States (Cytarabine (Phase 1 only), Lintuzumab-Ac225, Furosemide (Phase 1 only))
Completed
- AML
- Cytarabine (Phase 1 only)
- +3 more
-
Los Angeles, California
- +16 more
Feb 22, 2022
Pancreatic Adenocarcinoma, Advanced Disease, Metastatic Disease Trial (18F-Fluoroazomycin arabinoside)
Withdrawn
- Pancreatic Adenocarcinoma
- +2 more
- 18F-Fluoroazomycin arabinoside
- (no location specified)
Feb 14, 2018
Breast Tumor Trial in Edmonton (18F-FAZA PET scan, FluGlucoScan Injection (18F-FDB) PET scan)
Terminated
- Breast Neoplasm
- 18F-FAZA PET scan
- FluGlucoScan Injection (18F-FDB) PET scan
-
Edmonton, Alberta, CanadaCross Cancer Institute
Aug 21, 2019
NSCLC Trial in Oxford (Atovaquone)
Completed
- Carcinoma, Non-Small-Cell Lung
-
Oxford, Oxfordshire, United KingdomChurchill Hospital
Sep 2, 2019
Renal Cell Carcinoma, Neuroendocrine Tumours Trial in Edmonton (18F-FAZA PET Imaging)
Terminated
- Renal Cell Carcinoma
- Neuroendocrine Tumours
- 18F-FAZA PET Imaging
-
Edmonton, Alberta, CanadaCross Cancer Institute
Aug 21, 2019
HIV, Leukoencephalopathy, Progressive Multifocal Trial in United States (Filgrastim, Cytarabine, Zidovudine)
Completed
- HIV Infections
- Leukoencephalopathy, Progressive Multifocal
- Filgrastim
- +4 more
-
Aurora, Colorado
- +8 more
Oct 28, 2021